Periodontal Management of Gingival Overgrowth in the Heart Transplant Patient: A Case Report

Journal of Periodontology

Volumn 68, Issue 11, 1997, Pages 1140-1146

  Khocht, Ahmed ^a,c   Schneider, Lawrence C ^b  

^a UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^b Department of Oral Pathology ^*

^c RUTGERS SCHOOL OF DENTAL MEDICINE   (United States)

Author keywords

Cyclosporin A adverse effects; Gingival hyperplasia etiology; Heart transplantation complications; Nifedipine adverse effects; Stomatitis etiology

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; NIFEDIPINE;

ARTICLE; CASE REPORT; CHEMICALLY INDUCED DISORDER; CONNECTIVE TISSUE; EPITHELIUM; FIBROSIS; FOLLOW UP; GINGIVA HYPERPLASIA; GINGIVA HYPERTROPHY; GINGIVA OVERGROWTH; GINGIVECTOMY; HEART TRANSPLANTATION; HUMAN; MALE; MICROBIOLOGY; MIDDLE AGED; PATHOLOGY; STOMATITIS; THRUSH;

CALCIUM CHANNEL BLOCKERS; CANDIDIASIS, ORAL; CONNECTIVE TISSUE; CYCLOSPORINE; EPITHELIUM; FIBROSIS; FOLLOW-UP STUDIES; GINGIVAL HYPERPLASIA; GINGIVAL HYPERTROPHY; GINGIVAL OVERGROWTH; GINGIVECTOMY; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; NIFEDIPINE; STOMATITIS;

EID: 0031262602     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.1997.68.11.1140     Document Type: Article

References (60)

1. McGregor CGA. Evolution of heart transplantation. Cardiol Clin 1990;8:3-10.
2. Carrel A, Guthrie CC. The transplantation of veins and organs. Am Med 1905;10:1101-1102.
3. Mann FC, Priestley JT, Markowitz J, Yater WM. Transplantation of the intact mammalian heart. Arch Surg 1933;26:219-224.
4. Goldberg M, Berman EF, Akman LC. Homologous transplantation of the canine heart. J Int Coll Surg 1958;30:575-586.
5. Cass MH, Brock R. Heart excision and replacement. Guys Hosp Rep 1959;108:285-290.
6. Lower RR, Shumway NE. Studies on orthotopic homotransplantation of the canine heart. Surg Forum 1960;11:18-19.
7. Lower RR, Dong E Jr, Shumway NE. Long-term survival of cardiac homografts. Surgery 1965;58:110-119.
8. Barnard CN. A human cardiac transplant: An interim report of a successful operation performed at Groote Schuur Hospital, Cape Town. S Afr Med J 1967;41:1271-1274.
9. Caves PK, Billingham ME, Schulz WP, Dong E Jr, Shumway NE. Transvenous biopsy from canine orthotopic heart allografts. Am Heart J 1973;85:525-530.
10. Caves PK, Stinson EB, Billingham ME, Shumway NE. Serial transvenous biopsy of the transplanted human heart: Improved management of acute rejection episodes. Lancet 1974;1:821-826.
11. Oyer PE, Stinson EB, Jamieson SW, et al. Cyclosporin A in cardiac allografting: A preliminary experience. Transplant Proc 1983;15: 1247-1252.
12. Wysocki GP, Laupacis A, Ulan RA, Stiller CR. Fibrous hyperplasia of the gingiva: A side effect of cyclosporin-A therapy. Oral Surg Oral Med Oral Pathol 1983;55:274-278.
13. Adams D, Davies G. Gingival hyperplasia associated with cyclosporin: A report of two cases. Br Dent J 1984;157:89-90.
14. Ramon Y, Behar S, Kishon Y, Engelberg IS. Gingival hyperplasia caused by nifedipine. A preliminary report. Int J Cardiol 1984;5: 195-206.
15. Lederman D, Lumerman H, Reuben S, Freedman PD. Gingival hyperplasia associated with nifedipine therapy. Report of a case. Oral Surg Oral Med Oral Pathol 1984;57:620-622.
16. Feehally J, Walls J, Mistry N, et al. Does nifedipine ameliorate cyclosporin A nephrotoxity? Br Med J 1987;295:310.
17. Graham RM. Cyclosporine: Mechanisms of action and toxicity. [Review]. Cleveland Clin J Med 1994;61:308-313.
18. Physicians' Desk Reference. Montvale, NJ: Medical Economics Company; 1996:1110.
19. Scudeletti M, Puppo F, Lanza L, et al. Comparison of two glucocorticoid preparations (deflazacort and prednisone) in the treatment of immune-mediated diseases. Eur J Clin Pharmacol 1993;45(Suppl 1):S29-S34.
20. Scudeletti M, Pende D, Barabino A, et al. Effect of single oral doses of prednisone and deflazacort on human lymphocyte distribution and functions. Analysis with monoclonal antibodies. Adv Exp Med Biol 1984;171:335-344.
21. Physicians' Desk Reference. Montvale, NJ: Medical Economics Company; 1996:1972.
22. Physicians' Desk Reference. Montvale, NJ: Medical Economics Company; 1996:2623.
23. Rateitschak-Pluss EM, Hefti A, Lortscher R, Thiel G. Initial observations that cyclosporin-A induces gingival enlargement in man. J Clin Periodontol 1983;10:273-276.
24. Daley TD, Wysocki GP, Day C. Clinical and pharmacologic correlations in cyclosporine-induced gingival hyperplasia. Oral Surg Oral Med Oral Pathol 1986;62:417-421.
25. McGaw WT, Lam S, Coates J. Cyclosporin-induced gingival overgrowth: Correlation with dental plaque scores, gingivitis scores, and cyclosporin levels in serum and saliva. Oral Surg Oral Med Oral Pathol 1987;64:293-297.
26. McGaw WT, Ten Cate AR. A role for collagen phagocytosis by fibroblasts in scar remodelling: An ultrastructural stereologic study. J Invest Dermatol 1983;81:375-378.
27. McGaw WT, Porter H. Cyclosporine-induced gingival overgrowth: An ultrastructural stereologic study. Oral Surg Oral Med Oral Pathol 1988;65:186-190.
28. Kirk AJ, Omar I, Bateman DN, Dark JH. Cyclosporine-associated hypertension in cardiopulmonary transplantation. The beneficial effect of nifedipine on renal function. Transplantation 1989;48:428-430.
29. Barak S, Engelberg IS, Hiss J. Gingival hyperplasia caused by nifedipine. Histopathologic findings. J Periodontol 1987;58:639-642.
30. Wynn R. Calcium channel blockers and gingival hyperplasia. Gen Dent 1991;39:240-243.
31. Slavin J, Taylor J. Cyclosporin, nifedipine, and gingival hyperplasia. [Letter]. Lancet 1987;2:739.
32. Thomason JM, Seymour RA, Ellis JS, et al. Iatrogenic gingival overgrowth in cardiac transplantation. J Periodontol 1995;66:742-746.
33. Thomason JM, Seymour RA, Rice N. The prevalence and severity of cyclosporin and nifedipine-induced gingival overgrowth. J Clin Periodontol 1993;20:37-40.
34. Allman SD, McWhorter AG, Scale NS. Evaluation of cyclosporininduced gingival overgrowth in the pediatric transplant patient. Pediatr Dent 1994;16:36-40.
35. Goffin M. Gingival hyperplasia in a heart transplant patient treated with cyclosporin A and nifedipine. Rev Belge Med Dent 1991;46: 26-31.
36. Nishikawa S, Tada H, Hamasaki A, et al. Nifedipine-induced gingival hyperplasia: A clinical and in vitro study. J Periodontol 1991; 62:30-35.
37. Lynch MA, Brightman VJ, Greenberg MS. Burket's Oral Medicine. Philadelphia: JB Lippincott Company; 1984:221-236.
38. Neville B, Damm D, Allen C, Bouquot J. Oral and Maxillofacial Pathology. Philadelphia: W.B. Saunders Company; 1995:368.
39. Reichart PA, Schmidt-Westhausen A, Samaranayake LP, Philipsen HP Candida-associated palatal papillary hyperplasia in HIV infection. J Oral Pathol Med 1994;23:403-405.
40. Regezi J, Sciubba J. Oral Pathology, Clinical Pathologic Correlations. Philadelphia: W.B. Saunders Company; 1993:124.
41. Regezi J, Sciubba J. Oral Pathology, Clinical Pathologic Correlations. Philadelphia: W.B. Saunders Company; 1993:176.
42. Darwazeh AM, Lamey PJ, MacFarlane TW, McCuish AC. The effect of exposure to chlorhexidine gluconate in vitro and in vivo on in vitro adhesion of Candida albicans to buccal epithelial cells from diabetic and non-diabetic subjects. J Oral Pathol Med 1994;23:130-132.
43. Persson RE, Truelove EL, LeResche L, Robinovitch MR. Therapeutic effects of daily or weekly chlorhexidine rinsing on oral health of a geriatric population. Oral Surg Oral Med Oral Pathol 1991;72: 184-191.
44. Arikan A, Kulak Y, Kadir T. Comparison of different treatment methods for localized and generalized simple denture stomatitis. J Oral Rehab 1995; 22:365-369.
45. Sheu WH, Wei J, Jeng CY, Fuh MM, Chen YD. Metabolic abnormalities following heart transplantation in patients with idiopathic cardiomyopathy. Horm Metab Res 1995;27:469-472.
46. Emrich LJ, Shlossman M, Genco RJ. Periodontal disease in noninsulin-dependent diabetes mellitus. J Periodontol 1991;62:123-131.
47. Finestone AJ, Boorujy SR. Diabetes mellitus and periodontal disease. Diabetes 1967;16:336-340.
48. Sznajder N, Carraro JJ, Rugna S, Sereday M. Periodontal findings in diabetic and nondiabetic patients. J Periodontol 1978; 49:445-448.
49. Mackenzie RS, Millard HD. Interrelated effects of diabetes, arteriosclerosis and calculus on alveolar bone loss. J Am Dent Assoc 1963;66:191-198.
50. Belting CM, Hiniker JJ, Dummett CO. Influence of diabetes mellitus on the severity of periodontal disease. J Periodontol 1964;35:476-480.
51. Benveniste R, Bixler D, Conneally PM. Periodontal disease in diabetes. J Periodontol 1967;38:271-279.
52. Cianciola LJ, Park BH, Bruck E, Mosovich L, Genco RJ. Prevalence of periodontal disease in insulin-dependent diabetes mellitus (juvenile diabetes). J Am Dent Assoc 1982;104:653-660.
53. Glavind L, Lund B, Löe H. The relationship between periodontal state and diabetes duration, insulin dosage and retinal changes. J Periodontol 1968;39:341-347.
54. Carranza F, Newman M. Clinical Periodontology. Philadelphia: W.B. Saunders Company; 1996:190-191.
55. Ueta E, Osaki T, Yoneda K, Yamamoto T. Prevalence of diabetes mellitus in odontogenic infections and oral candidiasis: An analysis of neutrophil suppression. J Oral Pathol Med 1993;22:168-174.
56. Zegarelli DJ. Fungal infections of the oral cavity. [Review]. Otolaryngol Clin North Am 1993;26:1069-1089.
57. Asante-Korang A, Boyle GJ, Webber SA, Miller SA, Fricker FJ. Experience of FK506 immune suppression in pediatric heart transplantation: A study of long-term adverse effects. J Heart Lung Transplant 1996;15:415-422.
58. Frabetti L, Checchi L, Finelli K. Cardiovascular effects of local anesthesia with epinephrine in periodontal treatment. Quintessence Int 1992;23:19-24.
59. Dajani AS, Bisno AL, Chung KJ, et al. Prevention of bacterial endocarditis. Recommendations by the American Heart Association. JAMA 1990;264:2919-2922.
60. Lynch MA, Brightman VJ, Greenberg MS. Burket's Oral Medicine. Philadelphia: JB Lippincott Company; 1984:777.